Israel-based Wearable textile medical device company HealthWatch has raised US $ 20 million from Shijiazhuang Yiling Pharmaceuticals. The company will use the funds to add more staff. The Chinese company will pay US $ 15 million for a 23 per cent stake in HealthWatch and pay another US $ 5 million for the rights to sell the company’s Master Caution device in China. Master Caution comprises an embedded processor to collect, store and process data together with an accelerometer, infra-red sensor and Bluetooth capability.
Approved by the US Food and Drug Administration and Europe’s CE mark, the device monitors ECGs as well as activity, respiration and skin temperature. Its sensors are interwoven into garments so that they appear as design elements rather than a monitoring device.
HealthWatch has developed smart garments that monitor the wearer for ECG and other vital signs and send the information in real time via smartphone.